Abstract
Today we are faced with an ever-increasingly varied number and type of therepeutic agents to treat rheumatoid arthritis. At one end there are the steroids, which must rate as the most powerful anti-inflammatory agents. A factor often overlooked by the ex-perimentalist in the field of inflammation is the fact that death is the most powerful anti-inflammatory agent available. So often one hears of experiments which produce anti-inflammatory effects, but make the animals moribund. The non-steroidal or aspirin-like drugs are another group of agents, usually acidic in nature. Among this group we would include indomethacin, butazolidin and the propionic acid derivatives.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arrigoni-Mortelli, E., Braume, E., Huskisson, E.C., Dieppe, P.A.: Pertussis vaccine oedema. Agents and Actions (in press) (1976)
Deporter, D.A., Dieppe, P.A., Willoughby, D.A.: The role of cyclic nucleotides in calcium pyrophosphate pleurisy. Agents and Actions (in press) (1976)
Dieppe, P.A., Crocker, P., Huskisson, E.C., Willoughby, D.A.: Apatite deposition disease: a new athropathia. Lancet 1976 II, 266
Ferreira, S.H., Moncada, S., Vane, J.R.: Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature New Biology 231, 237 (1971)
Giroud, J.P., Spector, W.G., Timsit, J., Willoughby, D.A.: The pharmacocellular assessment of slow acting anti-inflammatory agents. Agents and Actions 3/4, 205 (1973)
Huskisson, E.C., Scott, J., Balme, H.W., Dieppe, P.A., Trapnell, J., Willoughby, D.A.: Immunstimulant therapy with Levamisole for rheumatoid arthritis. Lancet 1976 II, 393–395
Rygan, C.B., Spector, W.G.: Macrophage turnover in inflamed connective tissue. Proc. roy. Soc. Lond. 175, 269 (1970)
Smith, J.B., Willis, A.L.: Aspirin selectively inhibits prostaglandin production in human platelets. Nature New Biology 231, 235 (1971)
Vane, J.R.: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biology 231, 232 (1971)
Waksman, B.H., Pearson, C.M., Sharp, J.T.: Adjuvant arthritis induced by injection in the rat. Arch. intern. Med. 5, 1 (1952)
Willoughby, D.A.: Effects of prostaglandins PGF2 and PGE1 on vascular permeability. J. Path. 96, 381 (1968)
Winter, CA., Risley, E.A., Nuss, G.W.: Carageen-induced oedema in the hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. exp. Biol. (N.Y.) 111, 544 (1962)
Zurier, R.B., Weissmann, G.: Effect of prostaglandin upon enzyme release from lysosomes and experimental arthritis. Proceedings of the ALZA conference on prostaglandins in cellular biology and the inflammatory process. Ramwell, P.W., Pharris, B.B. (eds.). New York: Plenum Press 1972, p. 154
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag
About this paper
Cite this paper
Willoughby, D.A., Dunn, C.J., Dieppe, P.A., Huskisson, E.C. (1977). Should We Suppress or Stimulate the Immune Response in Inflammation?. In: Glynn, L.E., Schlumberger, H.D. (eds) Experimental Models of Chronic Inflammatory Diseases. Bayer-Symposium, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66573-8_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-66573-8_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66575-2
Online ISBN: 978-3-642-66573-8
eBook Packages: Springer Book Archive